[1]
T. Bamedi, G. Dadashizadeh, A. Sarabandi, S. Tabibian, M. Shams, and A. Dorgalaleh, “Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders”, J Cell Mol Anesth, vol. 2, no. 1, pp. 19–23, Jan. 2017.